Get the content you want anytime you want.
REGISTER NOW | SIGN IN

The Contagion® Healthcare Associated Infections (HAI) specialty page provides HAI-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

HEALTHCARE-ASSOCIATED INFECTIONS (HAI) NEWS - Page 1

The C Diff Foundation Raises <i>Clostridium difficile</i> Infection (<i>C. difficile</i>) Clinical Trial Awareness Worldwide
In the USA: Nearly half a million Americans suffer from Clostridium difficile (C. diff.) infections in a single year according to a study released in 2015 by the Centers for Disease Control and Prevention.
Top Infectious Disease News of the Week—January 14, 2018
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
SHEA Releases Guidance on Duration of Contact Precautions for MDR Infections
SHEA has released expert guidance advising hospitals on when they can safely take patients with multidrug-resistant bacteria off of contact precautions.
Fidaxomicin Vs. Vancomycin: What's More Effective for Treating <i>C. difficile?</i>
A recent study compares the effectiveness of a novel fidaxomicin therapy with vancomycin for the treatment of C. difficile.
Top Infectious Disease News of the Week—January 7, 2018
In case you missed them, we've compiled the top 5 articles from this past week.
Metronidazole vs Vancomycin in Mild <i>Clostridium difficile</i> Infections
Lawrence J. Brandt, MD; Erik Dubberke, MD; Daniel E. Freedberg, MD, MS; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, discuss provider considerations when making decisions on how to treat patients with Clostridium difficile with the guideline-suggested agents, vancomycin and metronidazole.
ICU Patients Need More Protection from Superbugs
Patients in intensive care units are at greater risk of acquiring antimicrobial-resistant infections, and now, a group of international infectious disease experts ar calling for better protection for these high-risk patients.
 
Treatment Options for Invasive Aspergillosis, Mucormycosis Expanding
The development of mold-active azoles has led to enormous advancements in both prevention and treatment of invasive fungal infections.
FEATURED
We break down our top HIV news stories of 2017. Did you read them all?
x